BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $238,447 | -22.3% | 5,300 | -12.9% | 0.08% | -49.0% |
Q2 2022 | $307,000 | +28.5% | 6,082 | +173.0% | 0.15% | +8.5% |
Q4 2021 | $239,000 | -28.7% | 2,228 | -37.2% | 0.14% | -36.5% |
Q2 2019 | $335,000 | -59.9% | 3,550 | -67.9% | 0.22% | -9.4% |
Q4 2017 | $835,000 | – | 11,067 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
SIB LLC | 65,151 | $6,335,000 | 3.72% |
CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |